DENVER — Treatment with cannabidiol led to significant seizure reduction in those with focal-onset epilepsy and demonstrated a favorable safety profile, according to research presented at the American Academy of Neurology annual meeting. “Four-year [Expanded Access Program] results demonstrated that [cannabidiol] was associated with sustained seizure improvement in